These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38729787)

  • 1. Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in Italy.
    Calabria S; Ronconi G; Dondi L; Dondi L; Dell'Anno I; Nordon C; Rhodes K; Rogliani P; Dentali F; Martini N; Maggioni AP
    Eur J Intern Med; 2024 Sep; 127():97-104. PubMed ID: 38729787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Risk of Severe Cardiovascular Events Following Exacerbations of Chronic Obstructive Pulmonary Disease: Results of the EXACOS-CV Study in Japan.
    Matsunaga K; Yoshida Y; Makita N; Nishida K; Rhodes K; Nordon C
    Adv Ther; 2024 Aug; 41(8):3362-3377. PubMed ID: 38976123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease.
    Hawkins NM; Nordon C; Rhodes K; Talukdar M; McMullen S; Ekwaru P; Pham T; Randhawa AK; Sin DD
    Heart; 2024 Apr; 110(10):702-709. PubMed ID: 38182279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study.
    Yang HM; Ryu MH; Carey VJ; Kinney GL; Hokanson JE; Dransfield MT; Hersh CP; Silverman EK;
    J Am Heart Assoc; 2024 Jun; 13(11):e033882. PubMed ID: 38818936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.
    Swart KMA; Baak BN; Lemmens L; Penning-van Beest FJA; Bengtsson C; Lobier M; Hoti F; Vojinovic D; van Burk L; Rhodes K; Garbe E; Herings RMC; Nordon C; Simons SO
    Respir Res; 2023 Nov; 24(1):293. PubMed ID: 37990197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.
    Graul EL; Nordon C; Rhodes K; Marshall J; Menon S; Kallis C; Ioannides AE; Whittaker HR; Peters NS; Quint JK
    Am J Respir Crit Care Med; 2024 Apr; 209(8):960-972. PubMed ID: 38127850
    [No Abstract]   [Full Text] [Related]  

  • 7. Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial.
    Dransfield MT; Criner GJ; Halpin DMG; Han MK; Hartley B; Kalhan R; Lange P; Lipson DA; Martinez FJ; Midwinter D; Singh D; Wise R; Kunisaki KM
    J Am Heart Assoc; 2022 Sep; 11(18):e024350. PubMed ID: 36102236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbations Predict Severe Cardiovascular Events in Patients with COPD and Stable Cardiovascular Disease-A Nationwide, Population-Based Cohort Study.
    Løkke A; Hilberg O; Lange P; Ibsen R; Telg G; Stratelis G; Lykkegaard J
    Int J Chron Obstruct Pulmon Dis; 2023; 18():419-429. PubMed ID: 37034899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Death and Cardiovascular Events Following an Exacerbation of COPD: The EXACOS-CV US Study.
    Daniels K; Lanes S; Tave A; Pollack MF; Mannino DM; Criner G; Neikirk A; Rhodes K; Feigler N; Nordon C
    Int J Chron Obstruct Pulmon Dis; 2024; 19():225-241. PubMed ID: 38259591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal and Regional Variations in Chronic Obstructive Pulmonary Disease Exacerbation Rates in Adults without Cardiovascular Risk Factors.
    So JY; Zhao H; Voelker H; Reed RM; Sin D; Marchetti N; Criner GJ
    Ann Am Thorac Soc; 2018 Nov; 15(11):1296-1303. PubMed ID: 30063372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
    Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
    PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: Two nationwide population-based retrospective cohort studies.
    Lin CS; Liu CC; Yeh CC; Chang YC; Chung CL; Lane HL; Shih CC; Chen TL; Liao CC
    PLoS One; 2017; 12(8):e0181815. PubMed ID: 28813433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.
    Kunisaki KM; Dransfield MT; Anderson JA; Brook RD; Calverley PMA; Celli BR; Crim C; Hartley BF; Martinez FJ; Newby DE; Pragman AA; Vestbo J; Yates JC; Niewoehner DE;
    Am J Respir Crit Care Med; 2018 Jul; 198(1):51-57. PubMed ID: 29442524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidating the risk of cardiopulmonary consequences of an exacerbation of COPD: results of the EXACOS-CV study in Germany.
    Vogelmeier CF; Rhodes K; Garbe E; Abram M; Halbach M; Müllerová H; Kossack N; Timpel P; Kolb N; Nordon C
    BMJ Open Respir Res; 2024 Mar; 11(1):. PubMed ID: 38555102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between recent hospitalized COPD exacerbations and adverse outcomes after percutaneous coronary intervention: a nationwide cohort study.
    Lin WC; Chen CW; Lu CL; Lai WW; Huang MH; Tsai LM; Li CY; Lai CH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():169-179. PubMed ID: 30655664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Cardiovascular Events Associated with Chronic Obstructive Pulmonary Disease and/or Metabolic Syndrome: A Large-Scale Nationwide Population-Based Cohort Study.
    Noh E; Jeong H; Cho IS; Chang MS; Yu I; Park S; Lee JH; Lee SJ; Lee WY; Yong SJ; Kim SH
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1447-1456. PubMed ID: 38948908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology.
    Sadatsafavi M; Xie H; Etminan M; Johnson K; FitzGerald JM;
    PLoS One; 2018; 13(1):e0191243. PubMed ID: 29351331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
    Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Dynamics of Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease During Stable Disease and Exacerbations: Review of the Mechanisms and Implications.
    Simons SO; Heptinstall AB; Marjenberg Z; Marshall J; Mullerova H; Rogliani P; Nordon C; Hawkins NM
    Int J Chron Obstruct Pulmon Dis; 2024; 19():2259-2271. PubMed ID: 39411574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.